Alignment Healthcare (ALHC) to Release Quarterly Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) is scheduled to be posting its quarterly earnings results after the market closes on Thursday, August 1st. Analysts expect Alignment Healthcare to post earnings of ($0.14) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, May 2nd. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.01). Alignment Healthcare had a negative net margin of 7.81% and a negative return on equity of 91.06%. The business had revenue of $628.60 million during the quarter, compared to analyst estimates of $599.75 million. During the same period in the prior year, the business earned ($0.20) earnings per share. The firm’s quarterly revenue was up 43.1% compared to the same quarter last year. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alignment Healthcare Trading Up 2.3 %

Shares of ALHC stock opened at $8.76 on Wednesday. The business’s fifty day moving average price is $8.21 and its 200 day moving average price is $6.72. The firm has a market capitalization of $1.67 billion, a PE ratio of -10.43 and a beta of 1.43. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.57 and a quick ratio of 1.57. Alignment Healthcare has a 1-year low of $4.46 and a 1-year high of $10.16.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Bank of America upgraded shares of Alignment Healthcare from a “neutral” rating to a “buy” rating and increased their price target for the company from $7.75 to $11.00 in a report on Thursday, May 30th. Robert W. Baird started coverage on shares of Alignment Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $10.00 target price for the company. Piper Sandler raised Alignment Healthcare from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $6.00 to $8.00 in a research note on Wednesday, May 8th. Baird R W upgraded Alignment Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Finally, Stephens lifted their price objective on Alignment Healthcare from $6.00 to $7.00 and gave the stock an “equal weight” rating in a report on Friday, May 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $9.44.

Insider Activity

In related news, insider Christopher J. Joyce sold 15,034 shares of Alignment Healthcare stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $9.05, for a total transaction of $136,057.70. Following the completion of the sale, the insider now owns 406,912 shares in the company, valued at approximately $3,682,553.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Alignment Healthcare news, insider Christopher J. Joyce sold 16,000 shares of the stock in a transaction on Friday, June 14th. The stock was sold at an average price of $8.01, for a total transaction of $128,160.00. Following the transaction, the insider now owns 422,912 shares of the company’s stock, valued at approximately $3,387,525.12. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Christopher J. Joyce sold 15,034 shares of Alignment Healthcare stock in a transaction on Monday, July 15th. The shares were sold at an average price of $9.05, for a total value of $136,057.70. Following the completion of the sale, the insider now directly owns 406,912 shares of the company’s stock, valued at approximately $3,682,553.60. The disclosure for this sale can be found here. Insiders have sold 225,221 shares of company stock worth $2,142,155 over the last three months. 6.60% of the stock is currently owned by corporate insiders.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.